Family Studies of Type II CD36 Deficient Subjects: Linkage of a CD36 Allele to a Platelet-Specific mRNA Expression Defect(s) Causing Type II CD36 Deficiency

Summary

We performed family studies with type II CD36 deficiency. In the Mi.Y family, the proband (YII.1) and his brother (YII.2) displayed a type II deficient phenotype. In the mother(YI.2), binding of the anti CD36 monoclonal antibody, 0KM5, to both platelets and monocytes was reduced as compared to CD36 positive control cells. In the father (YI.1), while 0KM5 binding to his platelets was reduced, that of his monocytes was almost the same as normal control monocytes. Analysis of genomic DNA showed that YI.2, YII.1 and YII.2 were heterozygous for a proline90→serine mutation, and showed that both alleles of YI.1 did not have the mutation. Analysis of CD36 cDNA showed that the Pro90 form of CD36 cDNA could be detected in monocytes, but not in platelets from YII.1 and YII.2. These data indicated that YII.1 and YII.2 could be compound heterozygotes; an allele having a platelet-specific mRNA expression defect(s), which was responsible for the different CD36 expression between their platelets and monocytes, and the Ser90 allele. YI.1 was suggested to be a carrier of the platelet-specific silent allele. The platelet-specific silent allele was linked to a specific genotype of a polymorphic microsatellite sequence in the CD36 gene, supporting our hypothesis that mRNA expression defect(s) occurred at or near the CD36 gene. In a second type IICD36 deficient family, we also obtained results consistent with this hypothesis.

• References

• 1 Greenwalt DE, Lipsky RH, Ockenhouse CF, Ikeda H, Tandon NN, Jamieson GA. Membrane glycoprotein CD36: A review of its roles in adherence, signal transduction, and transfusion medicine. Blood 1992; 80: 1105-1115
• 2 Tandon NN, Kralisz U, Jamieson GA. Identification of GPIV (CD36) as a primary receptor for platelet-collagen adhesion. J Biol Chem 1989; 264: 7576-7583
• 3 Asch AS, Barnwell J, Silverstein RL, Nachman RL. Isolation of the thrombospondin membrane receptor. J Clin Invest 1987; 79: 1054-1061
• 4 Ockenhouse CF, Tandon NN, Magowan C, Jamieson GA, Chulay J. Identification of a platelet membrane glycoprotein as a falciparum malaria sequestration receptor. Science 1989; 243: 1469-1471
• 5 Endemann G, Stanton LW, Madden KS, Bryant CM, Tylert White R, Protter AA. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 1993; 268: 11811-11816
• 6 Ahumrad NA, El-Maghrabi MR, Amri EZ, Lopez E, Grimaidi PA. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. J Biol Chem 1993; 268: 17665-17668
• 7 Oquendo P, Hundt E, Lawler J, Seed B. CD36 directly mediates cyto-adherence of Plasmodium falciparum parasitized erythrocytes. Cell 1989; 58: 95-101
• 8 Noguchi K, Naito M, Tezuka K, Ishi S, Seimiya H, Sugimoto Y, Ammun E, Tsuruo T. cDNA expression cloning of the 85-kDa protein overexpressed in adriamycin-resistant cells. Biochem Biophys Res Comm 1993; 192: 88-95
• 9 Wyler B, Bortkicwiez DH, Bordet JC, McGregor JL. Cloning of the cDNA encoding human platelet CD36: comparison to PCR amplified fragments of monocyte, endothelial and HEL cells. Thromb Haemost 1993; 70: 500-505
• 10 Taylor KT, Tang Y, Sobieski DA, Lipsky RH. Characterization of two alternatively spliced 5’-untranslated exons of the human CD36 gene in different cell types. Gene 1993; 133: 205-212
• 11 Fernandez-Ruiz E, Armesilla AL, Sanchez-Madrid F, Vega EA. Gene encoding the collagen type I and thrombospondin receptor CD36 is located on chromosome 7ql 1.2. Genomics 1993; 17: 759-761
• 12 Tang Y, Taylor KT, Sobieski DA, Medved ES, Lipsky RH. Identification of a human CD36 isoform produced by exon skipping: Conservation of exon organization and pre-mRNA splicing patterns with a CD36 gene family member, CLA-1. J Biol Chem 1994; 269: 6011-6015
• 13 Armesilla AL, Vega MA. Structural organization of the gene for human CD36 glycoprotein. J Biol Chem 1994; 269: 18985-18991
• 14 Ikeda H, Mitani T, Ohnuma M, Haga H, Ohtzuka S, Kato T, Nakase T, Sekiguchi S. A new platelet-specific antigen, Nak^a, involved in the refractoriness of HLA-matched platelet transfusion. Vox Sang 1989; 57: 213-217
• 15 Tomiyama Y, Take H, Ikeda H, Mitani T, Furubayashi T, Mizutani H, Yamamoto N, Tandon NN, Sekiguchi S, Jamieson GA, Kurata Y, Yonezawa T, Tarui S. Identification of the platelet-specific alloantigen, Nak^a, on platelet membrane glycoprotein IV. Blood 1990; 75: 684-687
• 16 Yamamoto N, Ikeda H, Tandon NN, Herman J, Tomiyama Y, Mitani T, Sekiguchi S, Lipsky R, Kralisz U, Jamieson GA. A platelet membrane glycoprotein (GP) deficiency in healthy blood donors: Nak^a- platelet lack detectable GPIV (CD36). Blood 1990; 76: 1698-1703
• 17 Take H, Kashiwagi H, Tomiyama Y, Honda S, Honda Y, Mizutani H, Furubayashi T, Karasuno T, Nishiura T, Kanayama Y, Kurata Y, Matsuzawa Y. Expression of GPIV and Nak^aantigenon monocytes in Nak^a-negative subjectswhose platelets lack GPIV. Brit J Haematol 1993; 84: 387-391
• 18 Yamamoto N, Akamatsu N, Sakuraba H, Yamazaki H, Tanoue K. Platelet glycoprotein IV (CD36) deficiency is associated with the absence (type I) or the presence (type II) of glycoprotein IV on monocytes. Blood 1994; 83: 392-397
• 19 Kehrel B, Kronenberg A, Rauterberg J, Niesing-Bresch D, Niehues U, Kardoeus J, Schwippert B, Tschope D, van de Loo J, Clemetson KJ. Platelets deficient in glycoprotein Illb aggregate normally to collagen I and III but not to collagen type V. Blood 1993; 82: 3364-3370
• 20 Saelman EU M, Kehrel B, Kese KM, de Groot PG, Sixma JJ, Nieuwenhuis HK. Platelet adhesion to collagen and endothelial cell matrix under flow conditions is not dependenton platelet glycoprotein IV. Blood 1994; 83: 3240-3244
• 21 Kashiwagi H, Honda S, Tomiyama Y, Mizutani H, Take H, Honda Y, Kosugi S, Kanayama Y, Kurata Y, Matsuzawa Y. A novel polymorphism in glycoprotein IV (replacement of proline-90 by serine) predominates in subjects with platelet GPIV deficiency. Thromb Haemost 1993; 69: 481-484
• 22 Kashiwagi H, Tomiyama Y, Honda S, Kosugi S, Shiraga M, Nagao N, Sekiguchi S, Kanayama Y, Kurata Y, Matsuzawa Y. Molecular basis of CD36 deficiency: Evidence that a¹²⁸CșT substitution(prolin90șserine) in CD36 cDNA accounts for CD36 deficiency. J Clin Invest 1995; 95: 1040-1046
• 23 Lipsky RH, Ikeda H, Medved ES. A dinucleotide repeat in the third intron of CD36. Hum Mol Genet 1994; 3: 217
• 24 Kashiwagi H, Honda S, Take H, Mizutani H, Imai Y, Furubayashi T, Tomiyama Y, Kurata Y, Yonezawa T. Presenee of the whole coding region of GPIV mRNA in Nakⁿ-negative platelets. Int J Hematol 1993; 57: 153-161
• 25 Kashiwagi H, Honda S, Take H, Mizutani H, Imai Y, Tomiyama Y, Kurata Y, Yonezawa T. Detection of Nak^aantigen and GPIV (CD36) mRNA in monocytes of Nak^a-negative subjects. Thromb Haemost 1992; 67: 384-385
• 26 Kashiwagi H, Tomiyama Y, Kosugi S, Shiraga M, Lipsky RH, Kanayama Y, Kurata Y, Matsuzawa Y. Identification of molecular defects in a subject with type ICD36 deficiency. Blood 1994; 83: 3545-3552
• 27 Saltzman GC, Crowell JM, Martin JC, Trujillo TT, Romero A, Mullaney PF, LaBauve PM. Cell classification by laser light scattering:Identification and separation of unstained leukocytes. Acta Cytologica 1975; 19: 374-377
• 28 Chen YP, Djaffar I, Pidard D, Steiner B, Cieutat AM, Caen JP, Rasa JP. Ser-752șPro mutation in the cytoplasmic domain of integrin β3 subunit and defective activation of platelet integrin α_IIbβ₃(glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia. Proc Natl Acad Sci USA 1992; 89: 10169-10173
• 29 Tomiyama Y, Kashiwagi H, Kosugi S, Shiraga M, Kanayama Y, Kurata Y, Matsuzawa Y. Abnormal processing of the glycoprotein IIb transcript due to a nonsense mutation in exon 17 associated with Glanzmann’s thrombasthenia. Thromb Haemost 1995; 73: 756-762
• 30 Nichols WC, Lyons SE, Harrison JS, Cody RL, Ginsburg D. Severe von Willebrand disease due to a defect at the level of von Willebrand factor mRNA expression: detection by exonic PCR-restriction fragment length polymorphism analysis. Proc Natl Acad Sci USA 1991; 88: 3857-3861
• 31 Siguret V, Lavergne JM, Cherel G, Boyer-Neumann C, Ribba AS, Bahnak BR, Meyer D, Pietu G. A novel case of compound heterozygousity with ”Normandy’/type I von Willebrand disease (vWD) Direct demonstration of the segregationof one allele with a defective expression at the mRNA level causing type I vWD. Hum Genet 1994; 93: 95-102
• 32 Grandchamp B, Picat C, Kauppinen R, Mignotte V, Peltonen L, Mustajoki P, Romeo PH, Goossens RM, Nordmann Y. Molecular analysis of acute intermittent porphyria in a Finnish family with normal erythrocyte porphobilinogen deaminase. Eur J Clin Invest 1989; 19: 415-418
• 33 Conboy JG, Chasis JA, Winardi R, Tchernia G, Kan YW, Mohandas N. An isoform-specific mutation in the protein 4.1 gene results in hereditary elliptocytosis and complete deficiency of protein 4.1 in erythrocytes but not in nonerythroid cells. J Clin Invest 1993; 91: 77-82